| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.991 | 0.002 | 0.991 | Hypolipemic | 0.973 0.002 DBMET01745 0.978 0.002 DBMET01746 0.976 0.002 DBMET01747 0.99 0.002 DBMET00388 | ||
| 0.987 | 0.002 | 0.987 | Vasodilator, coronary | 0.767 0.004 DBMET01745 0.628 0.006 DBMET01746 0.887 0.003 DBMET01747 0.765 0.004 DBMET00388 | ||
| 0.929 | 0 | 0.939 | HMG CoA reductase inhibitor | 0.807 0.001 DBMET01745 0.851 0.001 DBMET01746 0.833 0.001 DBMET01747 0.939 0 DBMET00388 | DBMET00388 | |
| 0.857 | 0.009 | 0.868 | Transcription factor NF kappa B inhibitor | 0.868 0.009 DBMET01745 0.642 0.026 DBMET01746 0.861 0.009 DBMET01747 0.843 0.01 DBMET00388 | DBMET01745 | |
| 0.82 | 0 | 0.82 | Cholesterol synthesis inhibitor | 0.756 0.001 DBMET01745 0.778 0.001 DBMET01746 0.739 0.001 DBMET01747 0.796 0 DBMET00388 | ||
| 0.752 | 0.003 | 0.752 | NOS3 expression enhancer | 0.703 0.003 DBMET01745 0.63 0.004 DBMET01746 0.687 0.004 DBMET01747 0.713 0.003 DBMET00388 | ||
| 0.712 | 0.004 | 0.712 | Apoptosis antagonist | 0.643 0.005 DBMET01745 0.639 0.006 DBMET01746 0.652 0.005 DBMET01747 0.665 0.005 DBMET00388 | ||
| 0.693 | 0.005 | 0.693 | Immunosuppressant | 0.548 0.021 DBMET01745 0.608 0.012 DBMET01746 0.641 0.008 DBMET01747 0.656 0.007 DBMET00388 | ||
| 0.626 | 0.044 | 0.691 | Apoptosis agonist | 0.561 0.058 DBMET01745 0.619 0.045 DBMET01746 0.691 0.032 DBMET01747 0.493 0.076 DBMET00388 | DBMET01747 | |
| 0.585 | 0.005 | 0.604 | P-glycoprotein inhibitor | 0.583 0.005 DBMET01745 0.509 0.008 DBMET01746 0.461 0.011 DBMET01747 0.604 0.005 DBMET00388 | DBMET00388 | |
| 0.599 | 0.019 | 0.688 | Antibacterial | 0.688 0.01 DBMET01745 0.642 0.014 DBMET01746 0.635 0.015 DBMET01747 0.31 0.128 DBMET00388 | DBMET01745 | |
| 0.587 | 0.02 | 0.627 | Cholesterol antagonist | 0.472 0.037 DBMET01745 0.486 0.035 DBMET01746 0.423 0.045 DBMET01747 0.627 0.015 DBMET00388 | DBMET00388 | |
| 0.555 | 0.003 | 0.555 | ABCA1 expression enhancer | 0.456 0.004 DBMET01745 0.39 0.004 DBMET01746 0.498 0.003 DBMET01747 0.514 0.003 DBMET00388 | ||
| 0.425 | 0.031 | 0.435 | Antioxidant | 0.435 0.029 DBMET01745 0.328 0.052 DBMET01746 0.383 0.038 DBMET01747 0.347 0.047 DBMET00388 | DBMET01745 | |
| 0.41 | 0.021 | 0.459 | Vasodilator | 0.302 0.047 DBMET01745 0.221 0.088 DBMET01746 0.328 0.04 DBMET01747 0.459 0.015 DBMET00388 | DBMET00388 | |
| 0.381 | 0.002 | 0.381 | Thioredoxin reductase inhibitor | 0.299 0.003 DBMET01745 0.253 0.003 DBMET01746 0.289 0.003 DBMET01747 0.348 0.002 DBMET00388 | ||
| 0.47 | 0.101 | 0.513 | Antiinflammatory | 0.513 0.082 DBMET01745 0.489 0.092 DBMET01746 0.453 0.109 DBMET01747 0.458 0.106 DBMET00388 | DBMET01745 | |
| 0.362 | 0.002 | 0.362 | Integrin alphaLbeta2 antagonist | 0.116 0.003 DBMET01745 0.051 0.004 DBMET01746 0.126 0.003 DBMET01747 0.179 0.003 DBMET00388 | ||
| 0.358 | 0.011 | 0.467 | Protein kinase stimulant | 0.467 0.005 DBMET01745 0.32 0.014 DBMET01746 0.444 0.006 DBMET01747 0.165 0.059 DBMET00388 | DBMET01745 | |
| 0.315 | 0.014 | 0.315 | Neurotrophic factor enhancer | 0.271 0.028 DBMET01745 0.186 0.091 DBMET01746 0.219 0.06 DBMET01747 0.215 0.063 DBMET00388 | ||
| 0.323 | 0.024 | 0.323 | Hepatoprotectant | 0.314 0.026 DBMET01745 0.318 0.025 DBMET01746 0.307 0.028 DBMET01747 0.303 0.029 DBMET00388 | ||
| 0.334 | 0.037 | 0.416 | Angiogenesis stimulant | 0.314 0.044 DBMET01745 0.316 0.043 DBMET01746 0.347 0.033 DBMET01747 0.416 0.019 DBMET00388 | DBMET00388 | |
| 0.403 | 0.109 | 0.509 | Caspase 9 stimulant | 0.472 0.072 DBMET01745 0.285 0.211 DBMET01746 0.509 0.056 DBMET01747 | DBMET01747 | |
| 0.312 | 0.038 | 0.389 | Nitric oxide antagonist | 0.38 0.028 DBMET01745 0.389 0.027 DBMET01746 0.371 0.029 DBMET01747 0.283 0.044 DBMET00388 | DBMET01746 | |
| 0.273 | 0.009 | 0.273 | ATPase inhibitor | 0.211 0.029 DBMET01745 0.194 0.042 DBMET01746 0.182 0.055 DBMET00388 | ||
| 0.297 | 0.053 | 0.416 | Platelet antagonist | 0.254 0.071 DBMET01745 0.198 0.102 DBMET01746 0.273 0.063 DBMET01747 0.416 0.024 DBMET00388 | DBMET00388 | |
| 0.248 | 0.013 | 0.296 | Neurotrophic factor | 0.232 0.016 DBMET01745 0.296 0.008 DBMET01746 0.22 0.019 DBMET01747 0.202 0.027 DBMET00388 | DBMET01746 | |
| 0.286 | 0.058 | 0.363 | Hypoglycemic | 0.191 0.121 DBMET01745 0.222 0.095 DBMET01746 0.234 0.087 DBMET01747 0.363 0.035 DBMET00388 | DBMET00388 | |
| 0.294 | 0.078 | 0.294 | Interleukin 2 agonist | 0.229 0.144 DBMET01745 0.288 0.083 DBMET01746 0.229 0.144 DBMET01747 0.283 0.087 DBMET00388 | ||
| 0.225 | 0.017 | 0.323 | Antineoplastic antibiotic | 0.323 0.008 DBMET01745 0.253 0.014 DBMET01746 0.204 0.02 DBMET01747 0.125 0.037 DBMET00388 | DBMET01745 | |
| 0.214 | 0.018 | 0.23 | Farnesoid X receptor antagonist | 0.202 0.021 DBMET01745 0.18 0.029 DBMET01746 0.23 0.015 DBMET01747 0.168 0.036 DBMET00388 | DBMET01747 | |
| 0.191 | 0.005 | 0.264 | Protein 50S ribosomal subunit inhibitor | 0.197 0.005 DBMET01745 0.264 0.004 DBMET01746 0.164 0.006 DBMET01747 0.086 0.017 DBMET00388 | DBMET01746 | |
| 0.212 | 0.035 | 0.212 | Interleukin 6 antagonist | 0.159 0.077 DBMET01745 0.138 0.108 DBMET01746 0.13 0.124 DBMET01747 0.178 0.056 DBMET00388 | ||
| 0.183 | 0.024 | 0.241 | Microtubule formation inhibitor | 0.212 0.017 DBMET01745 0.231 0.014 DBMET01746 0.241 0.011 DBMET01747 0.12 0.061 DBMET00388 | DBMET01747 | |
| 0.16 | 0.005 | 0.187 | ATPase (Vacuolar H+) inhibitor | 0.148 0.008 DBMET01745 0.187 0.003 DBMET01746 0.149 0.008 DBMET01747 0.118 0.021 DBMET00388 | DBMET01746 | |
| 0.152 | 0.002 | 0.152 | ICAM 1 antagonist | 0.028 0.008 DBMET01745 0.031 0.006 DBMET01747 0.032 0.005 DBMET00388 | ||
| 0.264 | 0.114 | 0.289 | Sodium/bile acid cotransporter inhibitor | 0.271 0.107 DBMET01745 0.231 0.149 DBMET01746 0.238 0.141 DBMET01747 0.289 0.089 DBMET00388 | DBMET00388 | |
| 0.148 | 0.013 | 0.155 | Interleukin 12 antagonist | 0.14 0.016 DBMET01745 0.139 0.016 DBMET01746 0.155 0.011 DBMET01747 | DBMET01747 | |
| 0.139 | 0.006 | 0.139 | Acetyl-CoA transferase inhibitor | 0.099 0.014 DBMET01745 0.081 0.02 DBMET01746 0.089 0.017 DBMET01747 0.1 0.013 DBMET00388 | ||
| 0.12 | 0.003 | 0.12 | LFA antagonist | 0.026 0.022 DBMET01745 0.078 0.004 DBMET00388 | ||
| 0.133 | 0.029 | 0.157 | Anabolic | 0.151 0.017 DBMET01745 0.144 0.021 DBMET01746 0.157 0.014 DBMET01747 0.104 0.057 DBMET00388 | DBMET01747 | |
| 0.2 | 0.099 | 0.25 | Peptidyltransferase inhibitor | 0.25 0.05 DBMET01745 0.198 0.101 DBMET01746 0.191 0.111 DBMET01747 | DBMET01745 | |
| 0.208 | 0.112 | 0.295 | DNA synthesis inhibitor | 0.284 0.049 DBMET01745 0.2 0.124 DBMET01746 0.295 0.045 DBMET01747 | DBMET01747 | |
| 0.173 | 0.078 | 0.271 | Lipocortins synthesis antagonist | 0.271 0.027 DBMET01745 0.152 0.102 DBMET01747 0.199 0.057 DBMET00388 | DBMET01745 | |
| 0.098 | 0.01 | 0.112 | Nitric oxide donor | 0.084 0.019 DBMET01745 0.077 0.025 DBMET01746 0.085 0.018 DBMET01747 0.112 0.005 DBMET00388 | DBMET00388 | |
| 0.11 | 0.023 | 0.117 | Na+ K+ transporting ATPase inhibitor | 0.109 0.024 DBMET01745 0.106 0.026 DBMET01746 0.117 0.018 DBMET01747 0.096 0.035 DBMET00388 | DBMET01747 | |
| 0.106 | 0.02 | 0.106 | T cell inhibitor | 0.082 0.057 DBMET01745 0.086 0.047 DBMET01746 0.106 0.02 DBMET01747 0.087 0.044 DBMET00388 | ||
| 0.126 | 0.044 | 0.186 | AMP-activated protein kinase stimulant | 0.186 0.013 DBMET00388 | DBMET00388 | |
| 0.27 | 0.191 | 0.479 | Cyclophilin D inhibitor | 0.479 0.057 DBMET00388 | DBMET00388 | |
| 0.078 | 0.004 | 0.109 | Tubulin agonist | 0.074 0.004 DBMET01745 0.109 0.002 DBMET01746 0.072 0.004 DBMET01747 | DBMET01746 | |
| 0.074 | 0.003 | 0.074 | Integrin beta2 antagonist | 0.011 0.01 DBMET01747 | ||
| 0.11 | 0.043 | 0.11 | mTOR complex 1 inhibitor | |||
| 0.07 | 0.006 | 0.085 | Microtubule stabilization | 0.071 0.006 DBMET01745 0.085 0.004 DBMET01746 0.074 0.005 DBMET01747 0.048 0.03 DBMET00388 | DBMET01746 | |
| 0.081 | 0.019 | 0.094 | Bombesin 3 receptor antagonist | 0.07 0.024 DBMET01745 0.077 0.021 DBMET01746 0.07 0.024 DBMET01747 0.094 0.014 DBMET00388 | DBMET00388 | |
| 0.089 | 0.027 | 0.104 | Elastase 1 inhibitor | 0.081 0.034 DBMET01745 0.086 0.03 DBMET01746 0.083 0.033 DBMET01747 0.104 0.018 DBMET00388 | DBMET00388 | |
| 0.145 | 0.084 | 0.177 | Interferon gamma antagonist | 0.136 0.1 DBMET01745 0.162 0.064 DBMET01746 0.177 0.052 DBMET01747 0.15 0.078 DBMET00388 | DBMET01747 | |
| 0.073 | 0.018 | 0.077 | Prolactin release inhibitor | 0.077 0.014 DBMET00388 | DBMET00388 | |
| 0.056 | 0.004 | 0.058 | Elastase 3A inhibitor | 0.054 0.004 DBMET01745 0.056 0.004 DBMET01746 0.053 0.004 DBMET01747 0.058 0.004 DBMET00388 | DBMET00388 | |
| 0.056 | 0.004 | 0.058 | Elastase 2B inhibitor | 0.054 0.004 DBMET01745 0.056 0.004 DBMET01746 0.053 0.004 DBMET01747 0.058 0.004 DBMET00388 | DBMET00388 | |
| 0.056 | 0.004 | 0.058 | Elastase 3B inhibitor | 0.054 0.004 DBMET01745 0.056 0.004 DBMET01746 0.053 0.004 DBMET01747 0.058 0.004 DBMET00388 | DBMET00388 | |
| 0.11 | 0.062 | 0.126 | Interleukin 2 antagonist | 0.126 0.037 DBMET01746 | DBMET01746 | |
| 0.176 | 0.138 | 0.176 | DNA damaging | 0.166 0.15 DBMET00388 | ||
| 0.153 | 0.119 | 0.304 | Antimitotic | 0.304 0.042 DBMET01746 0.268 0.053 DBMET01747 | DBMET01746 | |
| 0.078 | 0.045 | 0.097 | CDC25A inhibitor | 0.067 0.062 DBMET01745 0.073 0.052 DBMET01746 0.097 0.029 DBMET01747 | DBMET01747 | |
| 0.103 | 0.077 | 0.103 | Electron transport complex I inhibitor | 0.101 0.08 DBMET01745 0.099 0.085 DBMET01747 | ||
| 0.025 | 0.005 | 0.042 | Antibiotic Macrolide-like | 0.026 0.005 DBMET01745 0.042 0.003 DBMET01746 0.027 0.005 DBMET01747 | DBMET01746 | |
| 0.058 | 0.039 | 0.063 | Lipocortins synthesis agonist | 0.063 0.03 DBMET01745 0.057 0.042 DBMET01746 0.056 0.046 DBMET01747 0.056 0.045 DBMET00388 | DBMET01745 | |
| 0.033 | 0.02 | 0.043 | RNA-directed RNA polymerase stimulant | 0.043 0.015 DBMET01745 0.033 0.02 DBMET01746 0.029 0.022 DBMET01747 | DBMET01745 | |
| 0.032 | 0.021 | 0.052 | ATP citrate lysase inhibitor | 0.029 0.026 DBMET01746 0.037 0.015 DBMET01747 0.052 0.007 DBMET00388 | DBMET00388 | |
| 0.195 | 0.184 | 0.327 | Antithrombotic | 0.197 0.181 DBMET01745 0.253 0.124 DBMET01746 0.199 0.178 DBMET01747 0.327 0.073 DBMET00388 | DBMET00388 | |
| 0.023 | 0.018 | 0.029 | Protein 30S ribosomal subunit inhibitor | 0.029 0.013 DBMET01745 0.022 0.019 DBMET01746 0.021 0.02 DBMET01747 | DBMET01745 | |
| 0.031 | 0.027 | 0.031 | Histone deacetylase 2 inhibitor | |||
| 0.015 | 0.012 | 0.017 | Antibiotic Tetracycline-like | 0.017 0.006 DBMET01745 0.015 0.013 DBMET01746 | DBMET01745 | |
| 0.129 | 0.127 | 0.149 | Ca2+-transporting ATPase inhibitor | 0.149 0.046 DBMET01745 | DBMET01745 | |
| 0.01 | 0.01 | 0.011 | Calcineurin inhibitor | 0.011 0.008 DBMET01746 | DBMET01746 | |
| 0.02 | 0.021 | 0.066 | Vitamin D receptor antagonist | 0.021 0.017 DBMET01745 0.066 0.004 DBMET01747 | DBMET01747 | |
| 0.022 | 0.025 | 0.071 | Leukotriene B4 receptor 1 antagonist | 0.071 0.004 DBMET01746 | DBMET01746 | |
| 0.12 | 0.125 | 0.138 | Arachidonic acid antagonist | 0.132 0.111 DBMET01745 0.138 0.103 DBMET00388 | DBMET00388 | |
| 0.105 | 0.11 | 0.281 | Lipid peroxidase inhibitor | 0.281 0.022 DBMET01745 0.11 0.105 DBMET01746 | DBMET01745 | |
| 0.025 | 0.031 | 0.2 | Prostaglandin agonist | 0.2 0.003 DBMET00388 | DBMET00388 | |
| 0.023 | 0.031 | 0.046 | Squalene synthetase inhibitor | 0.029 0.024 DBMET01745 0.046 0.016 DBMET00388 | DBMET00388 | |
| 0.038 | 0.045 | 0.075 | Estrogen agonist | 0.075 0.025 DBMET01747 | DBMET01747 | |
| 0.024 | 0.033 | 0.058 | Prostaglandin D2 agonist | 0.058 0.005 DBMET00388 | DBMET00388 | |
| 0.001 | 0.014 | 0.004 | Vitamin D-like | 0.004 0.003 DBMET01747 | DBMET01747 | |
| 0.027 | 0.04 | 0.054 | 5-Alpha-reductase inhibitor | 0.054 0.017 DBMET00388 | DBMET00388 | |
| 0.017 | 0.032 | 0.056 | Prostaglandin F2 alpha agonist | 0.056 0.004 DBMET00388 | DBMET00388 | |
| 0.119 | 0.137 | 0.166 | Melanin inhibitor | 0.166 0.062 DBMET01745 0.127 0.121 DBMET00388 | DBMET01745 | |
| 0.142 | 0.162 | 0.27 | Immunostimulant | 0.27 0.089 DBMET00388 | DBMET00388 | |
| 0.023 | 0.047 | 0.036 | Integrin antagonist | 0.036 0.033 DBMET00388 | DBMET00388 | |
| 0.069 | 0.1 | 0.114 | Protease inhibitor | 0.114 0.052 DBMET00388 | DBMET00388 | |
| 0.01 | 0.042 | 0.082 | Prostaglandin EP2 agonist | 0.082 0.004 DBMET00388 | DBMET00388 | |
| 0.007 | 0.041 | 0.035 | Prostacyclin agonist | 0.035 0.005 DBMET00388 | DBMET00388 | |
| 0.025 | 0.062 | 0.042 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.042 0.019 DBMET00388 | DBMET00388 | |
| 0.04 | 0.081 | 0.055 | Androgen agonist | 0.055 0.049 DBMET01745 | DBMET01745 | |
| 0.036 | 0.086 | 0.082 | Squalene epoxidase inhibitor | 0.082 0.009 DBMET00388 | DBMET00388 | |
| 0.008 | 0.06 | 0.072 | Estrogen receptor alpha agonist | 0.072 0.013 DBMET01747 | DBMET01747 | |
| 0.035 | 0.094 | 0.062 | Glucose-6-phosphate translocase inhibitor | 0.062 0.022 DBMET01745 | DBMET01745 | |
| 0.003 | 0.065 | 0.013 | Thromboxane agonist | 0.013 0.005 DBMET00388 | DBMET00388 | |
| 0.019 | 0.08 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.011 DBMET00388 | DBMET00388 | |
| 0.021 | 0.088 | 0.039 | HIV-1 protease inhibitor | 0.039 0.037 DBMET00388 | DBMET00388 | |
| 0.053 | 0.135 | 0.087 | Antineoplastic alkaloid | 0.087 0.057 DBMET01745 | DBMET01745 | |
| 0.069 | 0.154 | 0.107 | Toll-Like receptor 4 antagonist | 0.107 0.059 DBMET00388 | DBMET00388 | |
| 0.078 | 0.17 | 0.201 | Interleukin 4 antagonist | 0.201 0.022 DBMET01746 | DBMET01746 | |
| 0.005 | 0.101 | 0.054 | Prostaglandin E2 agonist | 0.054 0.005 DBMET00388 | DBMET00388 | |
| 0.157 | 0.256 | 0.191 | Caspase 3 stimulant | 0.191 0.183 DBMET01747 | DBMET01747 | |
| 0.112 | 0.212 | 0.14 | Phospholipase C inhibitor | 0.14 0.128 DBMET00388 | DBMET00388 | |
| 0.005 | 0.123 | 0.014 | Thromboxane A2 agonist | 0.014 0.013 DBMET00388 | DBMET00388 | |
| 0.017 | 0.142 | 0.159 | Prostaglandin EP2 antagonist | 0.159 0.009 DBMET00388 | DBMET00388 | |
| 0.059 | 0.189 | 0.133 | Bone formation stimulant | 0.133 0.074 DBMET01747 0.131 0.076 DBMET00388 | DBMET01747 | |
| 0.035 | 0.185 | 0.082 | Calcium channel L-type blocker | 0.082 0.038 DBMET00388 | DBMET00388 | |
| 0.03 | 0.184 | 0.154 | Prostaglandin F2 alpha antagonist | 0.154 0.004 DBMET00388 | DBMET00388 | |
| 0.027 | 0.197 | 0.075 | Parathyroid hormone antagonist | 0.075 0.005 DBMET01747 | DBMET01747 | |
| 0.032 | 0.214 | 0.087 | Topoisomerase I inhibitor | 0.087 0.082 DBMET01745 | DBMET01745 | |
| 0.007 | 0.207 | 0.029 | Leukotriene B4 receptor 2 antagonist | 0.029 0.009 DBMET01746 | DBMET01746 | |
| 0.068 | 0.269 | 0.326 | Insulin sensitizer | 0.326 0.012 DBMET00388 | DBMET00388 | |
| 0.048 | 0.261 | 0.146 | Psychostimulant | 0.146 0.12 DBMET00388 | DBMET00388 | |
| 0.071 | 0.293 | 0.121 | Growth hormone agonist | 0.121 0.12 DBMET00388 | DBMET00388 | |
| 0.008 | 0.23 | 0.03 | CYP24 inhibitor | 0.03 0.01 DBMET01747 | DBMET01747 | |
| 0.006 | 0.249 | 0.036 | Progesterone receptor B antagonist | 0.036 0.004 DBMET01747 | DBMET01747 | |
| 0.092 | 0.382 | 0.574 | Vasodilator, peripheral | 0.574 0.019 DBMET00388 | DBMET00388 | |
| 0.006 | 0.366 | 0.084 | Thromboxane A2 antagonist | 0.084 0.013 DBMET00388 | DBMET00388 | |
| 0.008 | 0.407 | 0.032 | Cyclophilin A inhibitor | 0.032 0.02 DBMET01746 | DBMET01746 | |
| 0.007 | 0.408 | 0.088 | Thromboxane antagonist | 0.088 0.016 DBMET00388 | DBMET00388 | |
| 0.065 | 0.542 | 0.177 | 5 Hydroxytryptamine release stimulant | 0.177 0.144 DBMET00388 | DBMET00388 | |
| 0.049 | 0.556 | 0.19 | Gastrin inhibitor | 0.19 0.164 DBMET00388 | DBMET00388 | |
| 0.017 | 0.708 | 0.058 | Cathepsin E inhibitor | 0.058 0.044 DBMET00388 | DBMET00388 | |
| 0.004 | 0.811 | 0.041 | Macrophage elastase inhibitor | 0.041 0.033 DBMET00388 | DBMET00388 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |